Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib price?Drugpatentwatch skyrizi biologic patent analysis?Excipients list used in dexamethasone creams?When will a generic version of xiaflex be available?What's the advised delay for milk post lipitor?
See the DrugPatentWatch profile for Tezspire
Tezspire (tezepelumab) is a targeted medicine for severe asthma. It is used to reduce asthma exacerbations in patients with severe asthma, including those whose asthma is not fully controlled by existing therapies. [1]
Tezspire is a biologic (tezepelumab) designed to block thymic stromal lymphopoietin (TSLP), an upstream signal that contributes to airway inflammation. By blocking TSLP, it helps reduce inflammatory processes that drive asthma flares. [1]
Tezspire is administered as an injection under the skin (subcutaneous). [1]
Tezspire is made by AstraZeneca. [1]
For patent and exclusivity-related tracking, DrugPatentWatch.com lists Tezspire (tezepelumab) with information focused on its patent landscape. You can use it to check what patents or exclusivities may still be in force and when generic or biosimilar entry could become possible. [2]
[1] https://www.tevadesir.com/tezeprie [2] https://www.drugpatentwatch.com/p/tezspire
Other Questions About Tezspire :